* If you want to update the article please login/register
Inflammation induced by lipopolysaccharide intake may also pose a threat to the metabolic stability by the expression of pro-inflammatory mediators, leading to immune system activation and subsequent metabolic transitions. In dairy cows, the effects of increased carnitine availability on hepatic metabolome profiles during an inflammation challenge have yet to be established. For the same period, herein, Holstein cows were supplemented with 25 g/d rumen-secured carnitine from 42 d prepartum to 126 d postpartum or assigned to the control group with no increase during the same period. We biopsied the liver of the cows before and after an intravenous injection of 0. 5 g/kg LPS. Conclusions Multivariate statistical studies revealed that hepatic metabolome profiles varied in connection with both the carnitine supplementation and the LPS challenge. Conclusions Our findings point to interactions between an acute hepatic inflammation response and biogenic amine metabolism, which can vary according to energy availability.
Source link: https://doi.org/10.1186/s40104-022-00741-z
Despite the various treatment options available for major depressive disorder, some patients' right treatment regimen for different patients is not the same. This review was designed to determine the effectiveness of adding L-carnitine to sertraline in the treatment of patients with MDD. 1000 mg of daily L-carnitine oral capsule with 100 mg of sertraline; and the control group received a placebo, as well as 100 mg of sertraline every day. Conclusion: L-carnitine supplementation in MDD patients did not have a significant effect on depression severity improvement.
Source link: https://doi.org/10.25259/gjmpbu_16_2022
The aim of this report was to compare the effects of L-carnitine supplementation along with a low calorie diet and low calorie diet alone on obesity reduction in obese women. Methods76 obese women with KOA were randomly divided into two low-calorie diet groups; the first group received the 1000 mg L-carnitine and the second group received the placebo. Physical fitness ; BMI ; at the conclusion of the study: The LCG showed significant improvements over the PLG in the total WOMAC scores at the end of the study. Conclusion: Oral administration of 1000 mg L-carnitine in 12 weeks may raise WOMAC scores and BMI, but it will not influence CRP, MDA, and lipid profiles.
Source link: https://doi.org/10.21203/rs.3.rs-22511/v1
The effects of L-carnitine and coenzyme Q10 on brook trout's growth results were explored in this study. At the end of the experiment, L-carnitine, coenzyme Q10, and L-carnitine/coenzyme Q10 supplemented groups demonstrated greater growth results than control Preferred groups, according to the study's results.
Source link: https://doi.org/10.17216/limnofish.886562
This review investigated the effects of 14 days of L-camitine supplementation on muscle and blood camitine fractions, muscle and blood lactate levels, and muscle and blood lactate concentrations, as a result of high-intensity sprint cycling endurance. Plasma total acid soluble and free camitine concentrations were significantly higher at all time points after supplementation. The L-camitine supplementation had no effect on muscle capillarine content and so could not change lactate accumulation during exercise, which was not particularly helpful.
Source link: https://doi.org/10.1123/ijsn.4.3.280
Abstract: We explore the case of a patient who at the age of 39 first experienced a bout of muscle weakness and transient ketoacidosis with biopsy-based fatty infiltration of the liver. Myopathy resisted for many years, but biopsy revealed significant deposition of lipid globules in type 1 muscle fibres;.
Source link: https://doi.org/10.1017/s0317167100026172
What is known already Endometriosis is a chronic disease of the female reproductive system that affects up to 15% of women of reproductive age. Mesenchymal stem cells secretly contain a variety of cytokines, growth factors, bioactive agents, and tissue regenerative components into a mesenchymal stem cell-conditioned medium. Histological examination was used to determine the induction of EMS. Ovaries of some mice in both normal and EMS groups were determined to help ensure the initiation of EMS. Participants/materials, location, and methods The adult female NMRI mice were divided into two normal and EMS-induced mice. In the BMSC-CM 50% group, the highest IVM rate in both the normal and EMS-induced mice was found. Compared to the control group, the experimental group, which contained 0. 3 and 0. 6 mg/ml of LC, as well as 25% and 50% of BMSC-CM therapies, had a dramatic decrease in ROS and NO levels as well as a significant rise in TAC levels. In normal groups, there was a dramatic rise in the mean cell number and TE cells in 1u00b5M RG's 0. 3 and 0. 6 mg/ml LC, 25% and 50% BMSC-CM. All treatment groups, except for the 1M RG group, showed a significant difference in the mean total cell population and TE cells in comparison to the control group. These results have broader ramifications of the study These studies may help identify the clinical use of LC and BMSC-CM in the assisted reproductive technology environment and pave the way to increase maturation culture.
Source link: https://doi.org/10.1093/humrep/deac107.289
The use of l-carnitine in chronic liver disease remains unclear. Methods: We searched the Cochrane Library, EMBASE, KMBASE, and Medline databases for all relevant studies published before April 2022 that tested the ability of l-carnitine or its derivatives to normalize liver enzymes in patients with chronic liver disease. We performed meta-analysis of the proportion of patients with alanine aminotransferase normalization and post-treatment serum aspartate aminotransferase and ALT values. l-carnitine supplementation has significantly reduced ALT and AST levels in patients with chronic liver disease, as well as normalized ALT values.
Source link: https://doi.org/10.3390/jpm12071053
Background/Aim: L -Carnitine is an important component of the fatty acid oxidation process, which is particularly relevant in the u03b2-oxidation reaction. Inadequate carnitine synthesis, and particularly in dialysis patients, leads to a lack of carnitine in hemodialysis patients. The aim of our study was to determine the effect of carnitine supplementation on plasma lipids, red blood cell count, and free radical metabolism. Methods: Twelve regularly dialyzed patients were treated to 15 mg/kg L -carnitine intravenously three times a week for six months. In comparison to the pretreatment samples, all supplemented patients had increased plasma free carnitine. Plasma total cholesterol and LDL cholesterol levels in the blood have been reduced. Intraerythrocyte reduced glutathione increased from 1. 65 u00b1 0. 25 to 2. 23 mmol/l, according to u00b1 0. 95 u00b1 0. 09 to 2. 06 mmol/l, with increased plasma antioxidant capacity increasing from 1. 65 mmol/l to 2. 06 mmol/l. Conclusion: Regular carnitine supplementation of hemodialysis patients can raise lipid metabolism, protein intake, red blood cell count, and antioxidant status.
Source link: https://doi.org/10.1159/000045993
In patients with chronic renal disease on haemodialysis, a defect in skeletal muscle mitochondrial metabolism contributes to a faulty metabolism. Carnitine, a protein that helps with normal mitochondrial function, has been shown to have significant benefits in such patients, so we conducted a study to see if carnitine improves muscle bioenergetics and function. Methods: Patients with end-stage renal disease who received placebo or intravenous L -carnitine for 16 weeks in a phase II randomised double-blind study. Mean plasma carnitine increased 10-fold in the carnitine group, but it was unchanged in the placebo group. Conclusions: The report did not show any significant effect of the 16 weeks L-carnitine supplementation on these objective measures of muscle metabolism and function on these objective measures of muscle metabolism and function. Muscle mitochondrial dysfunction is demonstrated by low blood flow and, therefore, reduced oxygen availability as underlying cause of muscle mitochondrial dysfunction in this disorder.
Source link: https://doi.org/10.1159/000078399
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions